SCHEMBL6568533

SCHEMBL6568533

O=C(Cc1c(Br)cc(Br)c(O)c1Br)N1CCCC1

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.46
HPGD P15428 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
MAPT P10636 4/20 0.41
KMT2A Q03164 3/20 0.41
POLB P06746 3/20 0.40
GAA P10253 2/20 0.39
MEN1 O00255 2/20 0.39
KDM4E B2RXH2 2/20 0.39
ALDH1A1 P00352 2/20 0.39
RECQL P46063 2/20 0.39
LMNA P02545 1/20 0.39
HTT P42858 1/20 0.39
ECE2 P0DPD6 1/20 0.38
RAB9A P51151 2/20 0.38
TSHR P16473 1/20 0.38
TP53 P04637 1/20 0.37
RXFP1 Q9HBX9 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6568622 0.98 NPC1 (0.49) NPC1HPGDSMN1; SMN2MAPTKMT2A
SCHEMBL6659568 0.71 TTR (0.39) ALDH1A1TSHR
SCHEMBL4384593 0.68 KMT2A (0.51) NPC1HPGDSMN1; SMN2MAPTKMT2A
SCHEMBL14969283 0.67 KMT2A (0.53) NPC1HPGDSMN1; SMN2MAPTKMT2A
SCHEMBL11324605 0.66 NPC1 (0.54) NPC1HPGDSMN1; SMN2KMT2APOLB
SCHEMBL16965312 0.65 KMT2A (0.54) NPC1HPGDSMN1; SMN2MAPTKMT2A
SCHEMBL2646798 0.65 HPGD (0.96) NPC1HPGDSMN1; SMN2MAPTKMT2A
SCHEMBL31424351 0.65 SMN1; SMN2 (0.60) NPC1HPGDSMN1; SMN2MAPTKMT2A
SCHEMBL12713119 0.65 SMN1; SMN2 (0.49) NPC1HPGDSMN1; SMN2MAPTKMT2A
SCHEMBL11317215 0.65 NPC1 (0.57) NPC1HPGDSMN1; SMN2KMT2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1402887-A1 New compounds for the inhibition of undesired cell proliferation and use thereof Jerini AG (DE) 2004-03-31 EP claimed
EP-1402888-A1 The use of substituted carbocyclic compounds as rotamases inhibitors Jerini AG (DE) 2004-03-31 EP claimed